HER2 Support Group Forums - Aragon initiates dosing in ARN-509 Phase 1/2 clinical trial for castration-resistant

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Aragon initiates dosing in ARN-509 Phase 1/2 clinical trial for castration-resistant (https://her2support.org/vbulletin/showthread.php?t=46317)

News	08-09-2010 06:31 AM

Aragon initiates dosing in ARN-509 Phase 1/2 clinical trial for castration-resistant

Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in patients with castration-resistant prostate cancer (CRPC).

More...

All times are GMT -7. The time now is 03:46 AM.